Press "Enter" to skip to content

Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke

Catalyst Pharmaceuticals Inc, rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its $375,000 treatment for a rare disease, saying the price was in line with similar products in the industry.

Original source: https://health.economictimes.indiatimes.com/news/pharma/catalyst-pharmaceuticals-defends-375000-drug-price-after-bernie-sanders-rebuke/68107453?utm_source=RSS&utm_medium=ETRSS

Also Read:   Generico closes Rs 10 crore venture debt financing from Alteria Capital